Search

Shirley V. Gembeh

Examiner (ID: 11999, Phone: (571)272-8504 , Office: P/1628 )

Most Active Art Unit
1615
Art Unit(s)
1628, 1615, 1614, 1618
Total Applications
2053
Issued Applications
1120
Pending Applications
147
Abandoned Applications
807

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13409943 [patent_doc_number] => 20180256514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY [patent_app_type] => utility [patent_app_number] => 15/813571 [patent_app_country] => US [patent_app_date] => 2017-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11832 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15813571 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/813571
METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY Nov 14, 2017 Abandoned
Array ( [id] => 18215341 [patent_doc_number] => 11590255 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Rubber-based soft gel skin adhesives [patent_app_type] => utility [patent_app_number] => 16/346655 [patent_app_country] => US [patent_app_date] => 2017-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 9983 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346655 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/346655
Rubber-based soft gel skin adhesives Nov 9, 2017 Issued
Array ( [id] => 12231784 [patent_doc_number] => 20180064646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYLMETHYLENEOXY)PHENYL]2,4-PYRIMIDINEDIAMINE' [patent_app_type] => utility [patent_app_number] => 15/808694 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16797 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15808694 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/808694
METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYLMETHYLENEOXY)PHENYL]2,4-PYRIMIDINEDIAMINE Nov 8, 2017 Abandoned
Array ( [id] => 18201133 [patent_doc_number] => 11583504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Stabilized formulations of lipid nanoparticles [patent_app_type] => utility [patent_app_number] => 16/348335 [patent_app_country] => US [patent_app_date] => 2017-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 48 [patent_no_of_words] => 48390 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348335 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348335
Stabilized formulations of lipid nanoparticles Nov 7, 2017 Issued
Array ( [id] => 17814255 [patent_doc_number] => 11419842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Neutral pH compositions of Docetaxel and human serum albumin [patent_app_type] => utility [patent_app_number] => 16/345615 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 45916 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345615 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/345615
Neutral pH compositions of Docetaxel and human serum albumin Oct 26, 2017 Issued
Array ( [id] => 15975919 [patent_doc_number] => 10668261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Sheet-like piece, sheet for promoting hair growth comprising sheet-like piece, and whitening and wrinkle ameliorating agent comprising sheet-like piece [patent_app_type] => utility [patent_app_number] => 15/790335 [patent_app_country] => US [patent_app_date] => 2017-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 41 [patent_no_of_words] => 12835 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15790335 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/790335
Sheet-like piece, sheet for promoting hair growth comprising sheet-like piece, and whitening and wrinkle ameliorating agent comprising sheet-like piece Oct 22, 2017 Issued
Array ( [id] => 12238523 [patent_doc_number] => 20180071386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION' [patent_app_type] => utility [patent_app_number] => 15/726665 [patent_app_country] => US [patent_app_date] => 2017-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12291 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15726665 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/726665
Silicon dioxide nanoparticles and the use thereof for vaccination Oct 5, 2017 Issued
Array ( [id] => 15491563 [patent_doc_number] => 20200045970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => PESTICIDAL MIXTURE [patent_app_type] => utility [patent_app_number] => 16/340545 [patent_app_country] => US [patent_app_date] => 2017-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340545 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/340545
PESTICIDAL MIXTURE Oct 3, 2017 Abandoned
Array ( [id] => 14357725 [patent_doc_number] => 10300143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Compositions for treating cancer and methods for making the same [patent_app_type] => utility [patent_app_number] => 15/722831 [patent_app_country] => US [patent_app_date] => 2017-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 93 [patent_no_of_words] => 38878 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15722831 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/722831
Compositions for treating cancer and methods for making the same Oct 1, 2017 Issued
Array ( [id] => 12259344 [patent_doc_number] => 20180078540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/719636 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16938 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15719636 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/719636
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor Sep 28, 2017 Issued
Array ( [id] => 17569970 [patent_doc_number] => 11318224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-03 [patent_title] => Nanofiber structures and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/336276 [patent_app_country] => US [patent_app_date] => 2017-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 38 [patent_no_of_words] => 7956 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336276 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/336276
Nanofiber structures and methods of use thereof Sep 27, 2017 Issued
Array ( [id] => 13968181 [patent_doc_number] => 10213423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-26 [patent_title] => Crenolanib for treating FLT3 mutated proliferative disorders [patent_app_type] => utility [patent_app_number] => 15/715274 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9505 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15715274 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/715274
Crenolanib for treating FLT3 mutated proliferative disorders Sep 25, 2017 Issued
Array ( [id] => 14578741 [patent_doc_number] => 20190216979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => MACROSCOPICALLY ALIGNABLE, INJECTABLE, SOFT HYDROGEL COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/331454 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331454 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331454
Macroscopically alignable, injectable, soft hydrogel composition Sep 24, 2017 Issued
Array ( [id] => 15738269 [patent_doc_number] => 20200108022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => ALBUMIN PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 16/321591 [patent_app_country] => US [patent_app_date] => 2017-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11430 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321591 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/321591
Albumin pharmaceutical composition and preparation method therefor Sep 20, 2017 Issued
Array ( [id] => 12904261 [patent_doc_number] => 20180193262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON [patent_app_type] => utility [patent_app_number] => 15/708440 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15708440 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/708440
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON Sep 18, 2017 Abandoned
Array ( [id] => 14261255 [patent_doc_number] => 10280179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-07 [patent_title] => Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death [patent_app_type] => utility [patent_app_number] => 15/707729 [patent_app_country] => US [patent_app_date] => 2017-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 66825 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1822 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707729 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/707729
Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death Sep 17, 2017 Issued
Array ( [id] => 16563192 [patent_doc_number] => 10888539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-12 [patent_title] => Methods of treating or preventing prostate cancer [patent_app_type] => utility [patent_app_number] => 15/703782 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17358 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703782 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/703782
Methods of treating or preventing prostate cancer Sep 12, 2017 Issued
Array ( [id] => 13127397 [patent_doc_number] => 10081619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Biaryl inhibitors of bruton's tyrosine kinase [patent_app_type] => utility [patent_app_number] => 15/699857 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79581 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699857 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/699857
Biaryl inhibitors of bruton's tyrosine kinase Sep 7, 2017 Issued
Array ( [id] => 17306251 [patent_doc_number] => 11207333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Compositions comprising triterpenoids and uses thereof for treating optic neuropathy [patent_app_type] => utility [patent_app_number] => 16/330486 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 32966 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330486 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/330486
Compositions comprising triterpenoids and uses thereof for treating optic neuropathy Sep 6, 2017 Issued
Array ( [id] => 17176830 [patent_doc_number] => 11154057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-26 [patent_title] => Use of nootkatone to treat mosquito infestations [patent_app_type] => utility [patent_app_number] => 16/328885 [patent_app_country] => US [patent_app_date] => 2017-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 13601 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328885 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/328885
Use of nootkatone to treat mosquito infestations Aug 31, 2017 Issued
Menu